Immunotherapy response induces divergent tertiary lymphoid structure morphologies in hepatocellular carcinoma

Authors: Shu, Daniel H., Ho, Won Jin, Kagohara, Luciane T., Girgis, Alexander, Shin, Sarah M., Danilova, Ludmila, Lee, Jae W., Sidiropoulos, Dimitrios N., Mitchell, Sarah, Munjal, Kabeer, Howe, Kathryn, Bendinelli, Kayla J., Kartalia, Emma, Qi, Hanfei, Mo, Guanglan, Montagne, Janelle, Leatherman, James M., Lopez-Vidal, Tamara Y., Zhu, Qingfeng, Huff, Amanda L., Yuan, Xuan, Hernandez, Alexei, Coyne, Erin M., Zaidi, Neeha, Zabransky, Daniel J., Engle, Logan L., Ogurtsova, Aleksandra, Baretti, Marina, Laheru, Daniel, Durham, Jennifer N., Wang, Hao, Sunshine, Joel C., Johnston, Robert J., Deutsch, Julie Stein, Taube, Janis M., Anders, Robert A., Jaffee, Elizabeth M., Fertig, Elana J., Yarchoan, Mark

Source: Nature Immunology; November 2024, Vol. 25 Issue: 11 p2110-2123, 14p

Nivolumab + Tacrolimus + Prednisone ± Ipilimumab for Kidney Transplant Recipients With Advanced Cutaneous Cancers.

Authors: Schenk, Kara M., Deutsch, Julie Stein, Chandra, Sunandana, Davar, Diwakar, Eroglu, Zeynep, Khushalani, Nikhil I., Luke, Jason J., Ott, Patrick A., Sosman, Jeffrey A., Aggarwal, Vikram, Schollenberger, Megan D., Sharfman, William H., Bibee, Kristin P., Scott, Jeffrey F., Loss, Manisha J., Wang, Hao, Qi, Hanfei, Sharon, Elad, Streicher, Howard, Chen, Helen X.

Source: Journal of Clinical Oncology; 3/20/2024, Vol. 42 Issue 9, p1011-1020, 19p

Comparing anti-tumor and anti-self immunity in a patient with melanoma receiving immune checkpoint blockade.

Authors: Chen, Shuming, McMiller, Tracee L., Soni, Abha, Succaria, Farah, Sidhom, John-William, Cappelli, Laura C., Casciola-Rosen, Livia A., Morales, Isaac R., Sankaran, Preethi, Berger, Alan E., Deutsch, Julie Stein, Zhu, Qingfeng C., Anders, Robert A., Hooper, Jody E., Pardoll, Drew M., Lipson, Evan J., Taube, Janis M., Topalian, Suzanne L.

Source: Journal of Translational Medicine; 3/5/2024, Vol. 22 Issue 1, p1-12, 12p

Subject Terms: IMMUNE checkpoint proteins, DRUG side effects, IPILIMUMAB, IMMUNITY, T cell receptors, GENE expression profiling, BIOMARKERS

Association between pathologic response and survival after neoadjuvant therapy in lung cancer

Authors: Deutsch, Julie Stein, Cimino-Mathews, Ashley, Thompson, Elizabeth, Provencio, Mariano, Forde, Patrick M., Spicer, Jonathan, Girard, Nicolas, Wang, Daphne, Anders, Robert A., Gabrielson, Edward, Illei, Peter, Jedrych, Jaroslaw, Danilova, Ludmila, Sunshine, Joel, Kerr, Keith M., Tran, Mia, Bushong, Judith, Cai, Junliang, Devas, Vipul, Neely, Jaclyn, Balli, David, Cottrell, Tricia R., Baras, Alex S., Taube, Janis M.

Source: Nature Medicine; January 2024, Vol. 30 Issue: 1 p218-228, 11p

Combinatorial biomarker for predicting outcomes to anti-PD-1 therapy in patients with metastatic clear cell renal cell carcinoma

Authors: Deutsch, Julie Stein, Lipson, Evan J., Danilova, Ludmila, Topalian, Suzanne L., Jedrych, Jaroslaw, Baraban, Ezra, Ged, Yasser, Singla, Nirmish, Choueiri, Toni K., Gupta, Saurabh, Motzer, Robert J., McDermott, David, Signoretti, Sabina, Atkins, Michael, Taube, Janis M.

Source: Cell Reports Medicine; February 2023, Vol. 4 Issue: 2